Ampio pharmaceuticals received audit opinion with going concern explanation

Englewood, colo., april 3, 2024 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse american: ampe) (the "company" or "ampio") today announced that, as previously disclosed in its annual report on form 10-k for the year ended december 31, 2023, which was filed on march 27, 2024 with the securities and exchange commission, the audited financial statements contained an unqualified audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the company's ability to continue as a going concern.
AMPE Ratings Summary
AMPE Quant Ranking